Clinical Trial Update: Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for autologous stem cell rescue with CD133+ selected cells in high-risk neuroblastoma; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Neuroblastoma | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2019-05-10